Exploring the growing interest in drug repurposing in oncology

There is a rapidly growing degree of global interest in the field of drug repurposing in oncology among members of the public and from some policy makers. Drug repurposing is defined as the reuse of drugs as anticancer therapies, according to press release of Anticancer Fund (ACF) issued on 4 February 2016. The promise of repurposing is that drugs with low toxicity and relatively low costs can be made available to patients in a rapidly reduced time-frame compared to the development of totally new drugs. Now a new joint project between the ACF, based in Belgium, and the Institute of Cancer Policy (ICP), King’s College London aims to change that. Read more here.